AR045917A1 - Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen - Google Patents
Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienenInfo
- Publication number
- AR045917A1 AR045917A1 ARP040102549A ARP040102549A AR045917A1 AR 045917 A1 AR045917 A1 AR 045917A1 AR P040102549 A ARP040102549 A AR P040102549A AR P040102549 A ARP040102549 A AR P040102549A AR 045917 A1 AR045917 A1 AR 045917A1
- Authority
- AR
- Argentina
- Prior art keywords
- mixtures
- activity
- pharmaceutical compositions
- compositions containing
- oligosaccharides
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title abstract 3
- 229920000669 heparin Polymers 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 3
- 229920001542 oligosaccharide Polymers 0.000 abstract 3
- 150000002482 oligosaccharides Chemical class 0.000 abstract 3
- 229960002897 heparin Drugs 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- -1 alkaline earth metal salt Chemical class 0.000 abstract 1
- 230000001858 anti-Xa Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0309041A FR2857971B1 (fr) | 2003-07-24 | 2003-07-24 | Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045917A1 true AR045917A1 (es) | 2005-11-16 |
Family
ID=33561051
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102549A AR045917A1 (es) | 2003-07-24 | 2004-07-19 | Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen |
Country Status (39)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7589145B2 (en) | 2004-04-15 | 2009-09-15 | Exxonmobil Chemical Patents Inc. | Syndiotactic rich polyolefins |
| EP2447285A3 (en) * | 2006-05-25 | 2013-01-16 | Momenta Pharmaceuticals, Inc. | Low molecular weight heparin composition and uses thereof |
| CN101711771B (zh) * | 2008-10-07 | 2015-12-09 | 上海喜恩医药科技发展有限公司 | 一种肝素衍生的多糖混合物及其制法和药物组合物 |
| DK3144325T3 (da) * | 2010-09-14 | 2021-01-25 | Univ Miyazaki | Heparin med høj renhed og fremstillingsfremgangsmåde dertil |
| WO2012072799A1 (en) | 2010-12-02 | 2012-06-07 | Aventis Pharma S.A. | New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample |
| CN102558392A (zh) * | 2010-12-14 | 2012-07-11 | 王芃 | 一种高抗FXa、低抗FIIa低分子肝素钠的制备方法 |
| CN102816255B (zh) * | 2011-06-10 | 2015-11-25 | 王芃 | 一种超低分子肝素钠的制备方法 |
| EP2980103B1 (en) | 2013-03-26 | 2020-11-04 | Jiuzhitang Co., Ltd. | Low molecular weight glycosaminoglycan derivative, pharmaceutical composition thereof, preparation method therefor and use thereof |
| CN103864959A (zh) * | 2014-04-03 | 2014-06-18 | 中国药科大学 | 一种肝素十二糖抗动脉粥样硬化的用途 |
| RU2639574C2 (ru) * | 2016-05-23 | 2017-12-21 | Алексей Георгиевич Александров | Способ получения низкомолекулярного гепарина |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL61201A (en) * | 1979-10-05 | 1984-09-30 | Choay Sa | Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them |
| FR2504928A1 (fr) * | 1981-04-29 | 1982-11-05 | Choay Sa | Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments |
| FR2669932B1 (fr) * | 1990-12-03 | 1994-07-01 | Sanofi Sa | Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent. |
| IT1284143B1 (it) * | 1996-09-06 | 1998-05-08 | Istituto Scient Di Chimica E B | Eparansolfati semi-sintetici ad elevata attivita' antimetastica e ridotto rischio emorragico |
| AU7753898A (en) * | 1997-06-06 | 1998-12-21 | Hamilton Civic Hospitals Research Development, Inc. | Modified low molecular weight heparin that inhibits clot associated coagulation factors |
| ES2161615B1 (es) * | 1999-07-23 | 2003-03-16 | Rovi Lab Farmaceut Sa | Composiciones de heparinas de muy bajo peso molecular. |
| JP4897991B2 (ja) * | 1999-07-23 | 2012-03-14 | ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ | 超低分子量ヘパリン組成物 |
| FR2800074B1 (fr) * | 1999-10-22 | 2001-12-21 | Aventis Pharma Sa | Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant |
| JP4585072B2 (ja) * | 2000-02-29 | 2010-11-24 | 扶桑薬品工業株式会社 | ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物 |
| FR2807043B1 (fr) * | 2000-03-28 | 2002-11-22 | Aventis Pharma Sa | Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation |
| US6969705B2 (en) * | 2000-07-21 | 2005-11-29 | Aventis Pharma S.A. | Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
| FR2811992B1 (fr) * | 2000-07-21 | 2003-07-04 | Aventis Pharma Sa | Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
| CA2458852A1 (en) * | 2001-08-28 | 2003-03-06 | Leo Pharma A/S | Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate |
| FR2845686B1 (fr) * | 2002-10-10 | 2013-08-30 | Aventis Pharma Sa | Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant |
-
2003
- 2003-07-24 FR FR0309041A patent/FR2857971B1/fr not_active Expired - Fee Related
-
2004
- 2004-07-01 PE PE2004000632A patent/PE20050246A1/es not_active Application Discontinuation
- 2004-07-14 PA PA20048606801A patent/PA8606801A1/es unknown
- 2004-07-19 AR ARP040102549A patent/AR045917A1/es not_active Application Discontinuation
- 2004-07-21 HN HN2004000250A patent/HN2004000250A/es unknown
- 2004-07-22 DE DE602004030015T patent/DE602004030015D1/de not_active Expired - Lifetime
- 2004-07-22 SI SI200431594T patent/SI1651677T1/sl unknown
- 2004-07-22 RS YUP-2006/0044A patent/RS20060044A/sr unknown
- 2004-07-22 UA UAA200601969A patent/UA89356C2/ru unknown
- 2004-07-22 BR BRPI0412850-8A patent/BRPI0412850A/pt active Search and Examination
- 2004-07-22 PL PL04785991T patent/PL1651677T3/pl unknown
- 2004-07-22 ME MEP-116/08A patent/MEP11608A/xx unknown
- 2004-07-22 PT PT04785991T patent/PT1651677E/pt unknown
- 2004-07-22 CN CN2004800265420A patent/CN1852926B/zh not_active Expired - Fee Related
- 2004-07-22 AT AT04785991T patent/ATE487741T1/de active
- 2004-07-22 NZ NZ544717A patent/NZ544717A/en unknown
- 2004-07-22 KR KR1020067001609A patent/KR101125517B1/ko not_active Expired - Fee Related
- 2004-07-22 CA CA002533555A patent/CA2533555A1/fr not_active Abandoned
- 2004-07-22 JP JP2006520862A patent/JP4865552B2/ja not_active Expired - Fee Related
- 2004-07-22 MX MXPA06000336A patent/MXPA06000336A/es active IP Right Grant
- 2004-07-22 DK DK04785991.3T patent/DK1651677T3/da active
- 2004-07-22 WO PCT/FR2004/001943 patent/WO2005010051A2/fr not_active Ceased
- 2004-07-22 MY MYPI20042944A patent/MY136769A/en unknown
- 2004-07-22 AU AU2004259111A patent/AU2004259111B2/en not_active Ceased
- 2004-07-22 RU RU2006105384/04A patent/RU2346005C2/ru not_active IP Right Cessation
- 2004-07-22 ES ES04785991T patent/ES2355827T3/es not_active Expired - Lifetime
- 2004-07-22 EP EP04785991A patent/EP1651677B1/fr not_active Expired - Lifetime
- 2004-07-22 OA OA1200600025A patent/OA13197A/fr unknown
- 2004-07-23 UY UY28435A patent/UY28435A1/es unknown
- 2004-07-23 TW TW093121979A patent/TWI369208B/zh not_active IP Right Cessation
- 2004-07-23 GT GT200400145A patent/GT200400145A/es unknown
-
2006
- 2006-01-17 IL IL173206A patent/IL173206A/en not_active IP Right Cessation
- 2006-01-18 CR CR8201A patent/CR8201A/es unknown
- 2006-01-20 MA MA28745A patent/MA27928A1/fr unknown
- 2006-01-23 TN TNP2006000025A patent/TNSN06025A1/en unknown
- 2006-01-23 ZA ZA200600657A patent/ZA200600657B/en unknown
- 2006-01-23 EC EC2006006305A patent/ECSP066305A/es unknown
- 2006-02-20 NO NO20060821A patent/NO20060821L/no not_active Application Discontinuation
-
2011
- 2011-02-04 CY CY20111100132T patent/CY1111165T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029865A1 (es) | Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen | |
| TNSN05101A1 (fr) | Melanges de polysaccharides derives d'heparine leur preparation et les compositions pharmaceutiques les contenant | |
| Mourão | Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives | |
| Nahain et al. | Heparin mimetics with anticoagulant activity | |
| AR045917A1 (es) | Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen | |
| Mourão et al. | Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: sulphated fucose branches on the polysaccharide account for its antithrombotic action | |
| Damonte et al. | Sulfated seaweed polysaccharides as antiviral agents | |
| Schwörer et al. | Synthesis of a Targeted Library of Heparan Sulfate Hexa‐to Dodecasaccharides as Inhibitors of β‐Secretase: Potential Therapeutics for Alzheimer’s Disease | |
| Mourão et al. | Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm | |
| Kuo | Practical aspects of hyaluronan based medical products | |
| RU2010122324A (ru) | Полисахаридные композиции, не обладающие антикоагулянтными свойствами | |
| SI2794667T1 (en) | Low anticoagulant heparins | |
| Mohamed et al. | Synthetic approaches to L-iduronic acid and L-idose: Key building blocks for the preparation of glycosaminoglycan oligosaccharides | |
| KR900702372A (ko) | 참게 아메보사이트 라이세이트 g인자 활성화 저해제 | |
| DK3063177T3 (en) | DERIVATIVES OF N-DESULPHATED GLYCOSAMINOGLYCANES AND USE AS MEDICINES | |
| JP2004210715A5 (enExample) | ||
| RU2016116786A (ru) | Иммуностимулятор | |
| Ludwig et al. | Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities | |
| Scott et al. | Detection of secondary structure in glycosaminoglycans via the1H nmr signal of the acetamido NH group | |
| US9974803B2 (en) | Combination of glycosaminoglycans and cyclodextrins | |
| AR041555A1 (es) | Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen | |
| TW200745154A (en) | Oligosaccharides derived from fucoidan | |
| TH68733A (th) | ของผสมของพอลิแซคคาไรด์ที่มาจากเฮพาริน การเตรียมและสารผสมทางเภสัชกรรมที่มีของผสมนั้น | |
| Maaroufi et al. | Effect of oversulfated dermatan sulfate derivatives on platelet aggregation | |
| Behrens et al. | Heparosan glyco-conjugates of rFVIII and rFIX show prolonged circulating half-life in haemophilia mouse models |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |